Document is current
Any future updates will be listed below
-
Authors
Essouma, Mickael https://orcid.org/0000-0003-2364-5517
de Araujo, Daniel Brito https://orcid.org/0000-0002-4840-945X
Day, Jessica https://orcid.org/0000-0001-8528-4361
Conticini, Edoardo https://orcid.org/0000-0002-3974-6606
Riopel, Mary Anne https://orcid.org/0000-0001-9561-4723
Elias, Adriana Maluf https://orcid.org/0000-0003-0823-6459
Paula, Vitor Tavares https://orcid.org/0009-0005-1249-118X
Omori, Clarissa Harumi https://orcid.org/0009-0008-1771-3767
Guimarães, Julio Brandão https://orcid.org/0000-0002-5075-5896
Gibson, Daren https://orcid.org/0000-0001-9644-6514
Saad-Magalhaes, Claudia https://orcid.org/0000-0002-7631-7093
Appenzeller, Simone https://orcid.org/0000-0001-5075-4474
Schiffenbauer, Adam https://orcid.org/0000-0001-9964-9966
Machado, Pedro M https://orcid.org/0000-0002-8411-7972
Feldman, Brian M https://orcid.org/0000-0002-7813-9665
Paik, Julie J. https://orcid.org/0000-0001-8436-1601
Christopher-Stine, Lisa https://orcid.org/0000-0002-7150-7306
Rider, Lisa G. https://orcid.org/0000-0002-6912-2458
Reed, Ann https://orcid.org/0000-0002-4521-7647
van der Kooi, Anneke J. https://orcid.org/0000-0002-5261-5512
Marrani, Edoardo https://orcid.org/0000-0002-0346-3268
Naddaf, Elie https://orcid.org/0000-0001-6212-1236
Kirkhus, Eva https://orcid.org/0000-0002-8471-2261
Sanner, Helga https://orcid.org/0000-0001-7226-066X
Bauer-Ventura, Iazsmin https://orcid.org/0000-0003-1306-4241
Lilleker, James B https://orcid.org/0000-0002-9230-4137
Gupta, Latika https://orcid.org/0000-0003-2753-2990
Lucchini, Matteo https://orcid.org/0000-0002-0447-2297
Dimachkie, Mazen M https://orcid.org/0000-0002-7148-989X
Tolend, Mirkamal https://orcid.org/0000-0002-4111-0156
Arabi, Tamima Mohamad Abou https://orcid.org/0000-0002-3368-1354
Moghadam-Kia, Siamak https://orcid.org/0000-0002-0994-1590
O’Hanlon, Susan https://orcid.org/0000-0002-9599-4081
Phaneuf, Susan
Shinjo, Samuel Katsuyuki https://orcid.org/0000-0002-3682-4517
Doria, Andrea Schwarz https://orcid.org/0000-0003-3202-0447
-
Funding
Funding for this research was provided by:
National Institute of Environmental Health Sciences (ES101081)
National Institute of Environmental Health Sciences (ES101081)
- License Information
-
More Information
Article History
Received: 22 April 2024
Accepted: 8 June 2024
First Online: 8 July 2024
Declarations
:
: Not applicable.
: A previous version of this article was published on the pre-print platform MedRxiv: A protocol for a scoping review on the role of whole-body and dedicated body-part magnetic resonance imaging for assessment of adult and juvenile idiopathic inflammatory myopathies. Mickael Essouma, Daniel Brito de Araujo, Jessica Day, Latika Gupta, Adina Kay Knight, Ann Reed, Elie Naddaf, Adriana Maluf Elias Sallum, Edoardo Marrani, Edoardo Conticini, Simone Appenzeller, Adina Kay Knight, Mazen Dimachkie, Tamima Mohamad Abou, Daren Gibson, Eva Kirkhus, Anneke J van der Koi, James B Lilleker, Matteo Lucchini, Pedro Machado, Mary Anne Riopel, Helga Sanner, Adam Schiffenbauer, Julio Brandão Guimarães, Claudia Saad-Magalhaes, Susan O’Hanlon, Clarissa Harumi Omori, Susan Phaneuf, Helga Sanner, Siamak Moghadam-Kia, Mirkamal Tolend, Iazsmin Bauer Ventura, Lisa G Rider, Lisa Christopher-Stine, Julie J Paik, Brian Feldman, Samuel Katsuyuki Shinjo, Andrea Schwarz Doria. medRxiv 2024.03.26.24304925; doi: .
: JD is the recipient of the Sylvia and Charles Viertel Charitable Foundation Clinical Investigator Award, the John T Reid Charitable Trust Centenary Fellowship, the RACP Australian Rheumatology Association and D.E.V Starr Research Establishment Fellowship and the Royal Melbourne Hospital Victor Hurley Medical research Grant in Aid. SA is the recipient CNPQ 305981/2023-4 grant. MMD serves or recently served as a consultant for Abata/Third Rock, Abcuro, Amicus, ArgenX, Astellas, Cabaletta Bio, Catalyst, CNSA, Covance/Labcorp, CSL-Behring, Dianthus, Horizon, EMD Serono/Merck, Ig Society, Inc, Ipsen, Janssen, Medlink, Nuvig, Octapharma, Priovant, Sanofi Genzyme, Shire Takeda, TACT/Treat NMD, UCB Biopharma, Valenza Bio and Wolters Kluwer Health/UpToDate. MMD received research grants or contracts or educational grants from Alexion/ AstraZeneca, Alnylam Pharmaceuticals, Amicus, Argenx, Bristol-Myers Squibb, Catalyst, CSL-Behring, FDA/OOPD, GlaxoSmithKline, Genentech, Grifols, Mitsubishi Tanabe Pharma, MDA, NIH, Novartis, Octapharma, Orphazyme, Ra Pharma/UCB, Sanofi Genzyme, Sarepta Therapeutics, Shire Takeda, Spark Therapeutics, The Myositis Association, and UCB Biopharma / RaPharma. AS and LR are funded by the intramural research program of the National Institute of Environmental Health Sciences, National Institutes of Health (project ES101081). Other authors declare that they do not have any competing interests.
